pHLOGISTIX
pHLOGISTIX LLC was organized in 2011 to develop, market, and license neurodiagnostic and therapeutic technologies, focusing on traumatic brain injury (TBI), concussion, and neurodegenerative disorders. The company aims to develop innovative diagnostic and therapeutic solutions, including blood-based biomarkers and companion diagnostics, to improve the detection, monitoring, and treatment of brain injuries and related conditions.
Industries
Products
Blood-based multi-analyte diagnostic kit for concussion (in development)
A multi-analyte blood diagnostic intended to detect mitochondrial and other injury-related biomarkers to identify concussion and monitor transition to post-concussion syndrome.
Handheld point-of-injury diagnostic device (prototype/in development)
A portable diagnostic device concept intended to rapidly detect blood-based biomarkers at the point of injury using disposable cassettes.
Theranostic drug development program (preclinical)
Program to develop therapeutics linked to companion diagnostics aimed at modulating neuroinflammation and coagulation pathways after brain injury; IND-seeking strategy described.
Blood-based multi-analyte diagnostic kit for concussion (in development)
A multi-analyte blood diagnostic intended to detect mitochondrial and other injury-related biomarkers to identify concussion and monitor transition to post-concussion syndrome.
Handheld point-of-injury diagnostic device (prototype/in development)
A portable diagnostic device concept intended to rapidly detect blood-based biomarkers at the point of injury using disposable cassettes.
Theranostic drug development program (preclinical)
Program to develop therapeutics linked to companion diagnostics aimed at modulating neuroinflammation and coagulation pathways after brain injury; IND-seeking strategy described.
Services
Regulatory submission support and clinical trial monitoring
Preparation of regulatory filings (510(k), PMA planning, IND strategy) and monitoring support for clinical studies.
Companion diagnostic and assay development
Development of blood-based diagnostic assays and multi-analyte tests for concussion and related neurologic conditions, including assay design and validation planning.
Neuro-predictive data integration and analytics
Development of frameworks to integrate genetic, proteomic, imaging, physiologic and clinical data for predictive analysis of brain function and injury outcomes.
Preclinical study design and CRO coordination
Protocol development and coordination for animal studies (e.g., repetitive-concussion mouse models) and collaboration with contract research organizations.
Partnership and commercialization advisory
Advisory services for early-stage commercialization, investor presentations, and establishing industry or academic partnerships.
Regulatory submission support and clinical trial monitoring
Preparation of regulatory filings (510(k), PMA planning, IND strategy) and monitoring support for clinical studies.
Companion diagnostic and assay development
Development of blood-based diagnostic assays and multi-analyte tests for concussion and related neurologic conditions, including assay design and validation planning.
Neuro-predictive data integration and analytics
Development of frameworks to integrate genetic, proteomic, imaging, physiologic and clinical data for predictive analysis of brain function and injury outcomes.
Preclinical study design and CRO coordination
Protocol development and coordination for animal studies (e.g., repetitive-concussion mouse models) and collaboration with contract research organizations.
Partnership and commercialization advisory
Advisory services for early-stage commercialization, investor presentations, and establishing industry or academic partnerships.
Expertise Areas
- Biomarker discovery and validation
- Companion diagnostic (CDx) development
- Theranostic drug development
- Traumatic brain injury (TBI) and neuroinflammation research
Key Technologies
- Blood-based biomarker assays
- Mitochondrial DNA detection
- Protein biomarker assays
- Microarray / spinning-disk assay platforms